diabetes news, diabetes research news, diabetes information, diabetes kit, diabetes technology

5

NEWS

Medtronic CE Marks

As reported by Zacks Equity Research

in June 2021, Medtronic recently

secured two back-to-back European

regulatory approvals in the diabetes

management space, the first for its

InPen smart insulin pen, the second for

Guardian 4 sensor. Both received a CE

Mark. The commercial launch of both

will begin sometime later this year.

InPen got expanded approval for

multiple daily injections (MDI). Smart

MDI system automatically records

insulin doses, tracks active insulin and

recommends mealtime and correction

doses based on an auto-populated

bolus calculator. InPen is the first smart

insulin pen approved in Europe, which

can work together with real-time CGM

(continuous glucose monitoring) via

one convenient smartphone app. Inpen

was integrated to Medtronic's product

line following the company's acquisition

of connected insulin pen company,

Companion Medical, in September

2020.

The latest CE Mark approval for

the Guardian 4 sensor 3 enables it

to be integrated with the MiniMed

780G insulin pump system or InPen

or stand-alone CGM use. Notably, the

Guardian 4 sensor 3 does not require

any fingersticks for calibration or

diabetes treatment decisions. InPen

combined together with the Guardian 4

CGM system is claimed to provide realtime glucose

readings and insulin dose

information to the user in one place.

Rather than using multiple applications

with this integration, users will be able

to see all their information real-time in

one single app. This will help them with

smarter dosing decisions to manage

their sugar levels in one view rather

than taking the help of different apps.

The MiniMed 780G system with

Guardian 4 sensor will automatically

adjust and correct insulin delivery

every five minutes with no fingersticks.

These two latest innovations will enable

Medtronic to offer the only pump that

adjusts and corrects every five minutes

with an infusion set that lasts twice

as long. These will improve the user

experience of insulin pump therapy.

To read full story, CLICK HERE.

NHS pilot APS for T1

NHS Chief Executive Sir Simon Stevens has announced

a trial to support the wider roll-out of artificial pancreas

technology across England for people with Type 1

diabetes. Artificial pancreas systems, sometimes known

as closed-loop technology, enable an insulin pump and

a continuous glucose monitor to 'talk' to one another,

and deliver insulin automatically. The trial will offer

artificial pancreas systems to up to 1,000 people with

Type 1 diabetes in around 25 specialist centres across

England. The participants' data and experiences with

the technology will feed into the recently-announced

assessment of closed-loop systems by the National

Institute for Health and Care Excellence (NICE).

JDRF-funded artificial pancreas research, including

work at the University of Cambridge led by Professor

Roman Hovorka, has been key to development of closedloop systems. The charity's

research and advocacy

have also been central to increases in the availability of

continuous glucose monitoring (CGM), a core element

of hybrid closed-loop technology, on the NHS, with

pregnant women winning access from November 2020.

Sir Simon Stevens said of the plan, "Living with

diabetes is a daily challenge for millions of people across

England, and this closed loop technology has the potential

to make a remarkable difference to their lives. In a year

that marks a century since insulin was discovered - which

revolutionised the world of diabetes - this innovation

is a prime example of the NHS's continued progress in

modern medicine and technology."

Professor Partha Kar, NHS national speciality advisor

for diabetes, hailed the role of partner organisations such

as JDRF in that progress saying, "This new technology is

an extension of the fantastic work achieved by the NHS,

third sector and industry partners who are working

together to improve the lives of patients."

Hilary Nathan, Director of Communications and

Policy at JDRF added, "We welcome this trial, and we are

pleased to see NHS England is focused on England-wide

provision of the artificial pancreas. We are determined to

see UK-wide availability of life-changing Type 1 diabetes

technology options on the NHS."

Diabetes

breeds selfcriticism

We know that living with

diabetes or any other

chronic condition is mentally

exhausting. As a result,

more attention is now being

placed on the mental and

psychosocial burdens - and

the concept of resilience

has become core, Healthline

reports. A lab in Houston,

Texas, is dedicated to building

up resiliency in people with

diabetes. The Resilience and

Diabetes (RAD) Behavioral

Research Lab at Baylor

College of Medicine focuses on

two major areas: psychological

support for people with

serious and chronic conditions

and positive psychology. To

read the article in full, CLICK

HERE.

Index

  1. Free online Desang diabetes magazine, diabetes information
  2. Free online Desang diabetes magazine, diabetes information, Sue Marshall
  3. diabetes information, diabetes research, diabetes kit, diabetes management equipment
  4. diabetes news, diabetes research news, diabetes information, diabetes kit, diabetes technology
  5. diabetes news, diabetes research news, diabetes information, diabetes kit, diabetes technology
  6. diabetes news, diabetes research news, diabetes information, diabetes kit, diabetes technology
  7. Menarini GlucoMen Day needle-free CGM
  8. diabetes news, diabetes research news, diabetes information, diabetes kit, diabetes technology
  9. NHS Diabetes
  10. Dexcom G6 CGM, continuous glucose monitoring
  11. Dexcom G6 CGM, continuous glucose monitoring
  12. Ascensia Contour Next One Diabetes blood test meters
  13. Ascensia Contour Next One Diabetes blood test meters
  14. Medtrum A6 Touchcare Nano patch pump and CGM in harmony
  15. Medtrum Touchcare Nano patch pump and CGM in harmony
  16. diabetes research participant request Kings College Hospital
  17. diabetes research participant request Kings College Hospital
  18. diabetes research participant request Kings College Hospital
  19. diabetes research participant request Kings College Hospital, hypoglyaemia
  20. Desang diabetes magazine diabetes diet
  21. Abbott Freestyle Libre 2, Flash Glucose Monitoring, FSL2, Abbott Wellness Factory
  22. Desang diabetes magazine, frree online diabetes information
  23. Desang diabetes magazine, frree online diabetes information
  24. Diabetes kit diabetes management equipment
  25. insulin pump, Dana RS system, artificial pancreas, Advanced Therapeutics UK, CamAPS FX, Dexcom G6
  26. Diabetes management equipment, my diabetes kit, desang diabetes magazine
  27. New diabetes management equipment Afon Technology
  28. Page 0028
  29. diabetes kit, diabetes technology, ATTD conference, Sigi insulin patch pump, Terumo insulin patch pu
  30. Diabetes food news, Devon food and drink, Chef Peter Gorton
  31. Medtronic MiniMed 780G System Automated for an easier way to stabilise glucose levels.
  32. Diabetes food news, Devon food and drink, Chef Peter Gorton
  33. BD, Becton Dickinson, injection technique, BD pen needles, BD and Me
  34. diabetes food information, cooking fish, for the love of the sea, the female fisherman
  35. Page 0035
  36. diabetes food information, cooking fish, Nathan Outlaw's British Seafood
  37. Insulet Omnipod DASH insulin pump with insulin pods, podders, Omnipod DASH Personal Diabetes Manager
  38. Making Carbs Count, Carbohydrate counting for diabetes
  39. Diabetes diet, desang, diabetes food news, healthy food for diabetes, the glycaemic index for managi
  40. Diabetes diet, desang, diabetes food news, healthy food for diabetes, the glycaemic index for carboh
  41. Desang diabetes kitbags
  42. Free diabetes magazine

Related Issues